Atika Capital Management LLC Abb Vie Inc. Call Options Transaction History

Atika Capital Management LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $10.2 Million - $11.3 Million	-100,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $3.22 Million - $4.35 Million	40,000 Added 66.67%	100,000 $10.7 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $4.19 Million - $5.35 Million	60,000	60,000 $5.33 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Atika Capital Management LLC with notifications on news.